What Are Adequate Margins for Basal Cell Carcinoma?

Basal cell carcinoma is cut out with a margin, a rim of normal-looking skin around the visible spot, because the cancer often reaches past what the eye can see. For a small, clearly outlined tumor, that rim is only a few millimetres wide, and most people are cured with one operation. “Adequate” has two meanings, though: the width the surgeon draws before cutting, and the cancer-free edge the lab sees afterward. The second one decides whether you’re done.

The Standard Margin for a Low-Risk Tumor

For a well-outlined basal cell carcinoma smaller than 2 cm across, US guidelines recommend cutting 4 mm of normal-looking skin around it.¹ With that margin, the whole tumor comes out in more than 95% of cases.² Suggested margins for these low-risk tumors range from 2 to 4 mm.³ European guidance recommends 3 to 4 mm.⁴ The width matters: a 3 mm margin clears the tumor in about 85% of cases, leaving about 15% incomplete.⁵

Four millimetres is about the width of a pencil eraser, measured from the visible edge outward on every side. A 1 cm spot therefore becomes a circle of removed skin roughly 1.8 cm across. The surgeon usually shapes the cut into an ellipse about three times as long as it is wide so the skin closes flat, which is why the stitched line is often much longer than the spot itself.

The extra rim is there because basal cell carcinoma sends thin strands of cells beyond the edge you can see. They’re invisible to the eye and only show under a microscope.

The margin is measured outward from the tumor’s outline, so the surgeon first decides where the visible edge is, often with good light and a stretch of the skin. A tumor with a blurry or uneven border is harder to outline. The surgeon may then add a little to the plan or choose a different method rather than trust a guess. After a standard excision, about 2% of basal cell carcinomas return within 5 years.⁶

What Makes a Tumor Need a Wider Margin

Doctors sort basal cell carcinomas into low-risk and high-risk groups by the growth type seen under the microscope, the size, and the chance of coming back.⁷ For a high-risk tumor, US guidance suggests margins of 4 to 6 mm, and one study suggested 8 mm.⁸ European guidance suggests 5 to 10 mm.⁹ High-risk tumors vary so much that US guidelines set no single number and leave the width to the surgeon.¹⁰

Your pathology report names the tumor’s growth type, and some types spread further beneath normal-looking skin.¹¹ Morpheaform, infiltrative, metatypical, mixed and superficial types needed more rounds of Mohs to clear than nodular or micronodular types.¹² Large hidden spread was also more likely in men, in very fair skin that always burns, in people who’ve had a basal cell carcinoma before, and in aggressive types.¹³ One study found that depth mattered more than size or type in setting the margin needed.¹⁴ Mixed means more than one pattern, and the most aggressive one usually guides treatment. Ask your doctor which risk group your tumor falls into and why. A tumor that has already returned in the same place is treated more cautiously, because scar tissue from the earlier surgery can hide where the cancer now runs.

Location counts too. Dutch guidance treats tumors on the central face, the “H zone” around the eyes, nose, lips and ears, as high risk.¹⁵ Incomplete removal was more common on the side of the nose, elsewhere on the nose, and at the inner corner of the eye.¹⁶ Infiltrative and multifocal tumors were also more often removed incompletely.¹⁷

The central face is handled differently because the skin there is thin and sits close to cartilage, eyelids and lips. Surgeons can’t take wide rims without affecting function or appearance. So the face is where tissue-sparing methods like Mohs are most often chosen.

How Deep the Cut Goes

For nodular, superficial and other non-infiltrative tumors, removing tissue down into the fat under the skin cleared 95% of deep edges.¹⁸ Infiltrative tumors needed the next layer below the fat to reach the same 95% clearance.¹⁹ Some surgeons aim for the shallowest safe depth, just above the firm layer covering muscle, to keep the repair simple.²⁰ Around the eyes, deep margins tend to be largest, while on the nose they are smallest.²¹ On the nose and ears, cartilage sits close beneath, which limits how deep surgeons can go.

Reports often list a side (lateral) margin and a deep (bottom) margin separately. Cancer at the side edges is more common than at the deep edge. A deep-edge problem may mean a deeper re-excision rather than a wider one, so ask which edge was involved, since it changes the next step.

Standard Excision or Mohs Surgery

In standard excision, the surgeon removes a set margin and the lab checks the edges afterward, either during the operation or days later.²² Mohs surgery is an outpatient procedure that examines the edges while you wait and removes only the tissue that still holds cancer.²³ That keeps the wound as small as possible, which matters most on the face.

The lab handles the edges differently in each method. In standard excision, the lab usually samples the specimen in slices, so some of the edge is examined and some is inferred. In Mohs, the specimen is cut so the entire underside and outer edge are laid flat and examined, which is why the result is more complete. If cancer shows up, the map of the specimen tells the surgeon exactly where to return.

On a Mohs day, you’re numbed and a thin layer is removed, then you wait while it’s examined. If cancer remains at an edge, only that area is cut again. Most tumors clear in one or two rounds, but expect several hours at the clinic. The wound is often repaired the same day once it’s clear.

For facial basal cell carcinomas followed for 5 years, about 2% came back after Mohs versus 12% after standard excision.²⁴ That gap held clearly only for tumors that had already come back once, not for first-time tumors.²⁵ Over a shorter 18 months, differences were small and not reliable for either group.²⁶ For a recurrent facial tumor, Mohs is the preferred choice.²⁷

Mohs usually costs more for first-time tumors, and it pays for itself mainly when treating recurrent ones.²⁸

A few questions can sharpen the choice. Is my tumor first-time or recurrent, and is it on the face? Is its growth type aggressive? How would each option change my scar and the chance of a second surgery?

When the Report Says the Margin Isn’t Clear

A close margin and cancer at the edge are different findings. A close margin means cancer cells were found near the edge but did not touch it in the slices examined. A positive or incomplete margin means tumor cells reached the inked border, so some may remain in the body. The second usually leads to a discussion of further treatment, and the first often to closer follow-up, depending on the site.

In large series, about 7% to 10% of excisions come back with cancer at an edge.²⁹³⁰ Most involve the side edges rather than the deep edge.³¹ Even a cancer-free edge closer than 1 mm was linked to higher recurrence on the face.³² Tumors that returned had a median cancer-free edge of about 1.2 mm versus 1.9 mm for those that didn’t.³³

When incompletely removed tumors were cut again, about half still contained cancer.³⁴³⁵ Left untreated, about 1 in 4 came back within an average of 17 months.³⁶ Re-excision is the sensible choice in nearly all areas of the body.³⁷ One exception may be around the eye, except the inner corner, where re-excision found leftover cancer only about a quarter of the time.³⁸

When you talk through options, ask which edge was involved and whether it was side or deep. Ask whether Mohs is offered for the re-excision, especially on the face. Watchful waiting may be discussed in delicate spots, with regular skin checks. If you wait, report any new bump, scab or bleeding at the scar.

Why the Margin on Your Report Looks Smaller

Removed skin shrinks, on average by about 14% overall.³⁹ The healthy rim shrinks more, about 19%, than the tumor itself.⁴⁰ Measured margin widths dropped by 70% to 80% from planning to final lab reading.⁴¹

The shrinkage has two sources. Skin is held under tension on the body, so once it is cut free it springs back and contracts. Preparing the tissue for the microscope, including fixing and slicing, shrinks it further.

“Clear” means no cancer cells touched the inked edge in the slices examined. The millimetre figure is the gap between cancer and that edge after shrinkage. Any clear margin is good news, though under 1 mm may prompt closer follow-up.

Better Mapping Before the First Cut

Using a handheld magnifying scope to mark Mohs cuts lowered cancer at the side edges.⁴² It isn’t perfect: it underestimated the true edge in 6 of 29 margins in one study.⁴³ Laser skin imaging found the edge correctly about 93% of the time.⁴⁴ It showed cancer beyond the surgeon’s marks in 3 of 10 tumors.⁴⁵

A dermatoscope is a handheld lens with its own light that lets the doctor see structures in the skin that are invisible to the naked eye. Before Mohs, it can help the surgeon decide where the tumor really ends and mark the first cut accordingly. It’s quick and painless, and done in the same visit with no special preparation. If your tumor is poorly defined, ask whether its edges were checked this way.

Other Treatments That Skip Margin Checks

Scraping and burning leaves no edge for the lab to check, so success shows only over time.⁴⁶ The surgeon scrapes the tumor out with a spoon-shaped tool and then burns the base, usually repeating the cycle a few times. The surgeon judges clearance by feel, because healthy skin is firmer than tumor, which is why results depend on experience. When scrapings showed no leftover cancer, none came back; when they did and were left alone, 38% recurred.⁴⁷

This approach suits small low-risk tumors on the trunk or limbs. If you have it, ask whether the scrapings will be sent to the lab.

For large, advanced tumors, the pill vismodegib can shrink them before surgery.⁴⁸ Taken 3 months or more, it reduced wound size by about 27%.⁴⁹ Near the eye, follow-up surgery achieved clear margins in all treated people.⁵⁰ It’s meant for large tumors where surgery would otherwise remove an eye, ear or part of the nose.

Balancing Margins Against Your Scar

The goal is full removal with preserved function and an acceptable appearance.⁵¹ Sometimes limiting harm is wiser than demanding zero recurrence risk.⁵²⁵³

Your view of the scar counts. People who view their scars more negatively report worse quality of life,⁵⁴ and doctors may underestimate how much scarring upsets patients.⁵⁵

Tell your surgeon which areas matter most to you. Ask how the wound will be closed and how long the scar is expected to be, and what a second surgery would mean for appearance. Scars usually soften and fade over about a year.